<DOC>
	<DOCNO>NCT01759121</DOCNO>
	<brief_summary>This randomize , parallel control , clinical-trial aim evaluate therapeutic efficacy 532nm laser partially subthreshold panretinal photocoagulation PASCAL endpoint management function severe non-proliferative diabetic retinopathy .</brief_summary>
	<brief_title>Safety Effectiveness Study 532nm Laser Subthreshold Panretinal Photocoagulation Severe NPDR</brief_title>
	<detailed_description>This randomize , parallel control , clinical-trial aim evaluate therapeutic efficacy 532nm laser partially subthreshold panretinal photocoagulation PASCAL endpoint management function severe non-proliferative diabetic retinopathy : ( 1 ) To evaluate therapeutic effect 532nm laser partially subthreshold panretinal photocoagulation PASCAL endpoint management function severe non-proliferative diabetic retinopathy ; ( 2 ) To compare side effect 532nm laser partially subthreshold panretinal photocoagulation PASCAL endpoint management function retina traditional visible endpoint panretinal photocoagulation .</detailed_description>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>Diagnosis severe nonproliferative diabetic retinopathy Age:4580 year Best correct visual acuity ( BCVA ) ≥20/100 , Myopia≤6 degree ( 6D ) No photocoagulation ( PRP ) clinical trial major ocular surgery ( include cataract extraction , intraocular surgery ) within 3 month Ability willingness provide inform consent Participate clinical trial within 3 month Severe refractive medium turbidity ; Unable accept laser treatment nystagmus , etc Medically mentally unstable ( include cardiovascular disorder , cerebrovascular disease , liver kidney disease , hematological disorder psychosis Conditions opinion investigator would interfere trial result increase risk Conditions opinion investigator would preclude participation study</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>severe non-proliferative diabetic retinopathy</keyword>
	<keyword>subthreshold</keyword>
	<keyword>panretinal photocoagulation</keyword>
	<keyword>PASCAL</keyword>
	<keyword>endpoint management</keyword>
</DOC>